{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:05:48Z","timestamp":1773212748555,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1745-6215-15-158","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T23:05:04Z","timestamp":1399417504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Khai P","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poorva","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurdip","family":"Heer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val","family":"Redman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odette L","family":"Chagoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Dowswell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Freemantle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan N","family":"Townend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paramjit S","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J","family":"McManus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,6]]},"reference":[{"issue":"21","key":"2037_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14210","volume":"14","author":"C Black","year":"2010","unstructured":"Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, Smith C: Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010, 14 (21): 1-184.","journal-title":"Health Technol Assess"},{"issue":"4","key":"2037_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006, 145 (4): 247-254. 10.7326\/0003-4819-145-4-200608150-00004.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"2037_CR3","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation: K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kid Dis. 2002, 39 (Suppl 1): S1-S266.","journal-title":"Am J Kid Dis"},{"issue":"9731","key":"2037_CR4","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375 (9731): 2073-2081.","journal-title":"Lancet"},{"issue":"1","key":"2037_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","volume":"41","author":"J Coresh","year":"2003","unstructured":"Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis. 2003, 41 (1): 1-12. 10.1053\/ajkd.2003.50007.","journal-title":"Am J Kidney Dis"},{"issue":"13","key":"2037_CR6","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351 (13): 1296-1305. 10.1056\/NEJMoa041031.","journal-title":"N Engl J Med"},{"issue":"7","key":"2037_CR7","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"M Tonelli","year":"2006","unstructured":"Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006, 17 (7): 2034-2047. 10.1681\/ASN.2005101085.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2037_CR8","doi-asserted-by":"publisher","first-page":"e25920","DOI":"10.1371\/journal.pone.0025920","volume":"6","author":"M Mafham","year":"2011","unstructured":"Mafham M, Emberson J, Landray MJ, Wen CP, Baigent C: Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis. PLoS One. 2011, 6 (10): e25920-10.1371\/journal.pone.0025920.","journal-title":"PLoS One"},{"issue":"17","key":"2037_CR9","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298 (17): 2038-2047. 10.1001\/jama.298.17.2038.","journal-title":"JAMA"},{"issue":"4","key":"2037_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3122\/jabfm.2010.04.090129","volume":"23","author":"DD Murphree","year":"2010","unstructured":"Murphree DD, Thelen SM: Chronic kidney disease in primary care. J Am Board Fam Med. 2010, 23 (4): 542-550. 10.3122\/jabfm.2010.04.090129.","journal-title":"J Am Board Fam Med"},{"issue":"2","key":"2037_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/ndt\/gfm857","volume":"23","author":"N Richards","year":"2008","unstructured":"Richards N, Harris K, Whitfield M, O\u2019Donoghue D, Lewis R, Mansell M, Thomas S, Townend J, Eames M, Marcelli D: Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant. 2008, 23 (2): 549-555.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2037_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003, 42 (5): 1050-1065. 10.1161\/01.HYP.0000102971.85504.7c.","journal-title":"Hypertension"},{"issue":"Suppl 3","key":"2037_CR13","doi-asserted-by":"publisher","first-page":"iii73","DOI":"10.1093\/ndt\/gfs269","volume":"27","author":"M Kerr","year":"2012","unstructured":"Kerr M, Bray B, Medcalf J, O\u2019Donoghue DJ, Matthews B: Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012, 27 (Suppl 3): iii73-iii80.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2037_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2012.01.043","volume":"223","author":"WE Moody","year":"2012","unstructured":"Moody WE, Edwards NC, Madhani M, Chue CD, Steeds RP, Ferro CJ, Townend JN: Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association?. Atherosclerosis. 2012, 223 (1): 86-94. 10.1016\/j.atherosclerosis.2012.01.043.","journal-title":"Atherosclerosis"},{"issue":"11","key":"2037_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/hrt.2009.184879","volume":"96","author":"CD Chue","year":"2010","unstructured":"Chue CD, Townend JN, Steeds RP, Ferro CJ: Arterial stiffness in chronic kidney disease: causes and consequences. Heart. 2010, 96 (11): 817-823. 10.1136\/hrt.2009.184879.","journal-title":"Heart"},{"key":"2037_CR16","volume-title":"USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","author":"US Renal Data System","year":"2011","unstructured":"US Renal Data System: USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2011, Bethesda, MA: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease"},{"issue":"11","key":"2037_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/qjmed\/hcl101","volume":"99","author":"NC Edwards","year":"2006","unstructured":"Edwards NC, Steeds RP, Ferro CJ, Townend JN: The treatment of coronary artery disease in patients with chronic kidney disease. QJM. 2006, 99 (11): 723-736. 10.1093\/qjmed\/hcl101.","journal-title":"QJM"},{"issue":"22","key":"2037_CR18","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1161\/01.CIR.0000069826.36125.B4","volume":"107","author":"ME Safar","year":"2003","unstructured":"Safar ME, Levy BI, Struijker-Boudier H: Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003, 107 (22): 2864-2869. 10.1161\/01.CIR.0000069826.36125.B4.","journal-title":"Circulation"},{"issue":"5","key":"2037_CR19","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1046\/j.1523-1755.2001.0590051834.x","volume":"59","author":"JJ Mourad","year":"2001","unstructured":"Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, London GM, Safar ME: Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int. 2001, 59 (5): 1834-1841. 10.1046\/j.1523-1755.2001.0590051834.x.","journal-title":"Kidney Int"},{"issue":"6","key":"2037_CR20","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1097\/01.ASN.0000130566.69170.5E","volume":"15","author":"LP McMahon","year":"2004","unstructured":"McMahon LP, Roger SD, Levin A: Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease. J Am Soc Nephrol. 2004, 15 (6): 1640-1647. 10.1097\/01.ASN.0000130566.69170.5E.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2037_CR21","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/hrt.2007.137539","volume":"94","author":"NC Edwards","year":"2008","unstructured":"Edwards NC, Ferro CJ, Townend JN, Steeds RP: Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart. 2008, 94 (8): 1038-1043. 10.1136\/hrt.2007.137539.","journal-title":"Heart"},{"issue":"11","key":"2037_CR22","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","volume":"296","author":"SG Coca","year":"2006","unstructured":"Coca SG, Krumholz HM, Garg AX, Parikh CR: Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006, 296 (11): 1377-1384. 10.1001\/jama.296.11.1377.","journal-title":"JAMA"},{"issue":"10","key":"2037_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1742-1241.2012.03005.x","volume":"66","author":"KP Ng","year":"2012","unstructured":"Ng KP, Townend JN, Ferro CJ: Randomised-controlled trials in chronic kidney disease - a call to arms!. Int J Clin Pract. 2012, 66 (10): 913-915.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"2037_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ki.2011.223","volume":"80","author":"CA Herzog","year":"2011","unstructured":"Herzog CA, Asinger RW, Berger AK, Charytan DM, Diez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E: Cardiovascular disease in chronic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011, 80 (6): 572-586. 10.1038\/ki.2011.223.","journal-title":"Kidney Int"},{"issue":"2","key":"2037_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.ASN.0000100125.21491.46","volume":"15","author":"GF Strippoli","year":"2004","unstructured":"Strippoli GF, Craig JC, Schena FP: The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol. 2004, 15 (2): 411-419. 10.1097\/01.ASN.0000100125.21491.46.","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"2037_CR26","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","volume":"342","author":"J Concato","year":"2000","unstructured":"Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000, 342 (25): 1887-1892. 10.1056\/NEJM200006223422507.","journal-title":"N Engl J Med"},{"issue":"1","key":"2037_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000110567","volume":"26","author":"D Goldsmith","year":"2008","unstructured":"Goldsmith D: Negative outcome studies in end-stage renal disease. Blood Purif. 2008, 26 (1): 63-66. 10.1159\/000110567.","journal-title":"Blood Purif"},{"issue":"2","key":"2037_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","volume":"10","author":"GA Lancaster","year":"2004","unstructured":"Lancaster GA, Dodd S, Williamson PR: Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004, 10 (2): 307-312. 10.1111\/j..2002.384.doc.x.","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"2037_CR29","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1046\/j.1523-1755.2001.0600031131.x","volume":"60","author":"TH Jafar","year":"2001","unstructured":"Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS: Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int. 2001, 60 (3): 1131-1140. 10.1046\/j.1523-1755.2001.0600031131.x.","journal-title":"Kidney Int"},{"issue":"19","key":"2037_CR30","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1056\/NEJMoa042274","volume":"351","author":"AH Barnett","year":"2004","unstructured":"Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, Mustonen J: Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med. 2004, 351 (19): 1952-1961. 10.1056\/NEJMoa042274.","journal-title":"N Engl J Med"},{"issue":"1","key":"2037_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7326\/0003-4819-148-1-200801010-00190","volume":"148","author":"R Kunz","year":"2008","unstructured":"Kunz R, Friedrich C, Wolbers M, Mann JF: Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med. 2008, 148 (1): 30-48. 10.7326\/0003-4819-148-1-200801010-00190.","journal-title":"Ann Intern Med"},{"issue":"12","key":"2037_CR32","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1161\/01.CIR.0000143892.84582.60","volume":"110","author":"M Tonelli","year":"2004","unstructured":"Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M: Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation. 2004, 110 (12): 1557-1563. 10.1161\/01.CIR.0000143892.84582.60.","journal-title":"Circulation"},{"issue":"6","key":"2037_CR33","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.108.117531","volume":"52","author":"A Di Zhang","year":"2008","unstructured":"Di Zhang A, Nguyen Dinh Cat A, Soukaseum C, Escoubet B, Cherfa A, Messaoudi S, Delcayre C, Samuel JL, Jaisser F: Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling. Hypertension. 2008, 52 (6): 1060-1067. 10.1161\/HYPERTENSIONAHA.108.117531.","journal-title":"Hypertension"},{"issue":"7","key":"2037_CR34","first-page":"597","volume":"17","author":"M Iglarz","year":"2004","unstructured":"Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL: Involvement of oxidative stress in the profibrotic action of aldosterone: interaction with the renin-angiotensin system. Am J Hypertens. 2004, 17 (7): 597-603.","journal-title":"Am J Hypertens"},{"issue":"12","key":"2037_CR35","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1006\/jmcc.2002.2088","volume":"34","author":"C Delcayre","year":"2002","unstructured":"Delcayre C, Swynghedauw B: Molecular mechanisms of myocardial remodeling: the role of aldosterone. J Mol Cell Cardiol. 2002, 34 (12): 1577-1584. 10.1006\/jmcc.2002.2088.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"2037_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","volume":"17","author":"MJ Young","year":"2008","unstructured":"Young MJ: Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Curr Opin Nephrol Hypertens. 2008, 17 (2): 174-180. 10.1097\/MNH.0b013e3282f56854.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10","key":"2037_CR37","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ki.2011.505","volume":"81","author":"L Shavit","year":"2012","unstructured":"Shavit L, Lifschitz MD, Epstein M: Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms. Kidney Int. 2012, 81 (10): 955-968. 10.1038\/ki.2011.505.","journal-title":"Kidney Int"},{"issue":"18","key":"2037_CR38","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/01.CIR.99.18.2434","volume":"99","author":"J Blacher","year":"1999","unstructured":"Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999, 99 (18): 2434-2439. 10.1161\/01.CIR.99.18.2434.","journal-title":"Circulation"},{"issue":"3","key":"2037_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/qjmed\/hcn171","volume":"102","author":"B Ilyas","year":"2009","unstructured":"Ilyas B, Dhaun N, Markie D, Stansell P, Goddard J, Newby DE, Webb DJ: Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease. QJM. 2009, 102 (3): 183-191.","journal-title":"QJM"},{"issue":"10","key":"2037_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, the Randomized Aldactone Evaluation Study investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999, 341 (10): 709-717. 10.1056\/NEJM199909023411001.","journal-title":"N Engl J Med"},{"issue":"14","key":"2037_CR41","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003, 348 (14): 1309-1321. 10.1056\/NEJMoa030207.","journal-title":"N Engl J Med"},{"issue":"4","key":"2037_CR42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/eurheartj\/ehn543","volume":"30","author":"JA Ezekowitz","year":"2009","unstructured":"Ezekowitz JA, McAlister FA: Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J. 2009, 30 (4): 469-477.","journal-title":"Eur Heart J"},{"issue":"2","key":"2037_CR43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/j.ajkd.2007.10.040","volume":"51","author":"AS Bomback","year":"2008","unstructured":"Bomback AS, Kshirsagar AV, Amamoo MA, Klemmer PJ: Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review. Am J Kidney Dis. 2008, 51 (2): 199-211. 10.1053\/j.ajkd.2007.10.040.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2037_CR44","doi-asserted-by":"publisher","first-page":"542","DOI":"10.2215\/CJN.04750908","volume":"4","author":"SD Navaneethan","year":"2009","unstructured":"Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF: Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009, 4 (3): 542-551. 10.2215\/CJN.04750908.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2037_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jacc.2009.03.066","volume":"54","author":"NC Edwards","year":"2009","unstructured":"Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN: Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol. 2009, 54 (6): 505-512. 10.1016\/j.jacc.2009.03.066.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2037_CR46","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.amjcard.2010.07.018","volume":"106","author":"NC Edwards","year":"2010","unstructured":"Edwards NC, Ferro CJ, Kirkwood H, Chue CD, Young AA, Stewart PM, Steeds RP, Townend JN: Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease. Am J Cardiol. 2010, 106 (10): 1505-1511. 10.1016\/j.amjcard.2010.07.018.","journal-title":"Am J Cardiol"},{"issue":"3","key":"2037_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2125.2011.04102.x","volume":"73","author":"NC Edwards","year":"2012","unstructured":"Edwards NC, Steeds RP, Chue CD, Stewart PM, Ferro CJ, Townend JN: The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease. Br J Clin Pharmacol. 2012, 73 (3): 447-454. 10.1111\/j.1365-2125.2011.04102.x.","journal-title":"Br J Clin Pharmacol"},{"key":"2037_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2296-14-88","volume":"14","author":"SD Fraser","year":"2013","unstructured":"Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW: Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care. BMC Fam Pract. 2013, 14: 88-10.1186\/1471-2296-14-88.","journal-title":"BMC Fam Pract"},{"issue":"6","key":"2037_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, the Modification of Diet in Renal Disease study group: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999, 130 (6): 461-470. 10.7326\/0003-4819-130-6-199903160-00002.","journal-title":"Ann Intern Med"},{"issue":"12","key":"2037_CR50","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/hr.2009.154","volume":"32","author":"SS Hickson","year":"2009","unstructured":"Hickson SS, Butlin M, Broad J, Avolio AP, Wilkinson IB, McEniery CM: Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device. Hypertens Res. 2009, 32 (12): 1079-1085. 10.1038\/hr.2009.154.","journal-title":"Hypertens Res"},{"issue":"3","key":"2037_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/00126097-200106000-00008","volume":"6","author":"JM Wright","year":"2001","unstructured":"Wright JM, Mattu GS, Perry TL, Gelferc ME, Strange KD, Zorn A, Chen Y: Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit. 2001, 6 (3): 161-165. 10.1097\/00126097-200106000-00008.","journal-title":"Blood Press Monit"},{"issue":"5","key":"2037_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001, 33 (5): 337-343. 10.3109\/07853890109002087.","journal-title":"Ann Med"},{"key":"2037_CR53","volume-title":"Hypertension: Clinical Management for Primary Hypertension in Adults","author":"National Institute for Health and Care Excellence","year":"2011","unstructured":"National Institute for Health and Care Excellence: Hypertension: Clinical Management for Primary Hypertension in Adults. 2011, London: CG127"},{"key":"2037_CR54","unstructured":"University of Birmingham: Primary Care Clinical Research and Trials Unit (PC-CRTU). [http:\/\/www.birmingham.ac.uk\/research\/activity\/mds\/trials\/pccrtu\/index.aspx]"},{"key":"2037_CR55","volume-title":"The Discovery of Grounded Theory: Strategies for Qualitative Research","author":"B Glaser","year":"1967","unstructured":"Glaser B, Strauss A: The Discovery of Grounded Theory: Strategies for Qualitative Research. 1967, Chicago: Aldine"},{"key":"2037_CR56","volume-title":"Constructing Grounded Theory: A Practical Guide through Qualitative Analysis","author":"KC Charmaz","year":"2006","unstructured":"Charmaz KC: Constructing Grounded Theory: A Practical Guide through Qualitative Analysis. 2006, London: Sage"},{"key":"2037_CR57","unstructured":"QSR International Pty Ltd: NVivo qualitative data analysis software; Version 10. [http:\/\/www.qsrinternational.com\/products_nvivo.aspx?utm_source=NVivo+10+for+Mac]"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:48:20Z","timestamp":1630554500000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-15-158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,6]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-15-158","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,6]]},"assertion":[{"value":"2 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"158"}}